Dr Daniel Liang-Dar Hwang is a genetic epidemiologist and statistical geneticist by training. His research interests include sensory nutrition, causal modelling, and personalized nutrition. Dr Hwang applies statistical models to big data to understand genetic and environmental factors contributing to individual differences in taste and olfactory perception and their relationship with dietary behaviour and chronic conditions (See his research on taste perception in The Conversation). He develops methods for increasing statistical power for gene discovery, estimating intergenerational causal relationships, and personalized intervention. He also works with clinicians to investigate impaired chemosensory perception in cancer patients and COVID-19.

Daniel has a B.Sc from the National Taiwan University, majoring in Biochemical Science and Technology, and an M.Biotech from the University of Pennsylvania. Following graduation, he worked as a research technician in Danielle Reed's lab at the Monell Chemical Senses Center, where he first developed a keen interest in genetics and chemosensory perception. Later, he was awarded scholarships to complete an M.Sc in Nutrition at the University of Washington, under the supervision of Glen Duncan, and a PhD in Genetic Epidemiology at the QIMR Berghofer Medical Research Institute, under the supervision of Nicholas Martin and Margaret Wright. He then joined David Evans's group as a postdoc at the University of Queensland Diamantina Institute (now the Frazer Institute). Dr Hwang is an ARC DECRA Fellow at the Institute for Molecular Bioscience. He is also an Affiliated Scientist at the Monell Chemical Senses Center.

Dr Hwang has published more than 40 peer-reviewed publications. His work has been referred to in international health policy guidelines and a WHO report for the intervention of childhood obesity and in a global patent for personalized wine selection. He is on the editorial boards of BMC Medicine and Twin Research and Human Genetics. Dr Hwang is a Leadership Team member of the Global Consortium for Chemosensory Research, a global initiative to understand the relationship between smell loss and COVID-19 and foster the advancement of chemosensory science. He currently drives an international collaborative project to investigate the impact of COVID-19 vaccinations on long-COVID symptoms. Dr Hwang is a member of the National Committee for Nutrition of the Australian Academy of Science. He contributes to implementing the decadal plan for the science of nutrition in Australia.

Helen's interest in immune cell interactions across the tissue landscape started during her Master's and PhD with Dr. Ali Zaid at the Menzies Health Institute, Griffith University. Her PhD focused on defining the role of Interleukin-17 in virus-induced arthritis and exploring immunomodulation as a means of dampening synovial inflammation and damage. There, she was able to specialise in 3D imaging on optically-cleared tissues and high-dimensional flow cytometry. Helen received her PhD in 2022, before immediately starting a Postdoc position under Dr. Emma Gordon and Dr. Larisa Labzin at the Institute for Molecular Biosciences, University of Queensland. Her current research focuses on vascular complications in acute and long COVID-19. Specifically, Helen is developing a novel triple-culture model under air-liquid interface to investigate endothelial dysfunction and explore potential therapeutics in COVID-19.

Dr. Geng Wang is a postdoctoral research fellow specializing in statistical genetics and genetic epidemiology at the Institute for Molecular Bioscience, University of Queensland. His research focuses on the developmental origins of health and diseases, Mendelian randomization, the genetic susceptibility of complex traits and diseases, and the advancement of statistical genetics methodologies. Proficient in bioinformatics, statistical genetics, and clinical research, he has a background in clinical medicine and the biotechnology industry.

Dr. Wang obtained his bachelor's degree in clinical medicine and master's degree in internal medicine from Second Military Medical University (Shanghai, China) in 2012 and 2016, respectively. He served as a resident physician at Changzheng Hospital, affiliated with Second Military Medical University, from 2016 to 2017, specialising in rheumatology, before being promoted to an attending doctor. During his time in Shanghai, he was invited to visit the Translational Research Institute (Australia) twice in 2016 and 2017 for bioinformatics training and collaborative research.

Driven by his growing interest in human genetics, Dr. Wang pursued a Ph.D. in statistical genetics with Professor David Evans at the University of Queensland, which he successfully completed in 2023. Since then, he has continued his research in the aforementioned areas, contributing to the field with his diverse background and expertise.

Clara Jiang is a postdoctoral research fellow at the Institute for Molecular Bioscience, the University of Queensland. Clara's research focuses on using genomic and transcriptomic analysis to investigate the genetic basis of cardiovascular and psychiatric disorders, with a particular focus on female health, as well as using statistical genomic approaches to explore possible opportunities for drug repurposing. Clara graduated from the University of Queensland with Bachelor of Advanced Science (First Class Honours) in 2017, and was awarded the University Medal. Clara was awarded her PhD at the University of Queensland in 2021, where she utilised bioinformatic approaches and molecular experiments to decipher the genetic aetiology of breast cancer, specifically the regulatory role of transposons or 'jumping genes' in modulating the transcriptional landscape in the cancer state. Clara is also a UQ Wellness ambassador and an advocate for promoting equity, diversity and inclusion in academia.

As a cell biologist specialising in molecular and cell biology and stem cell biology, my work focuses on cardiovascular development, stem cell-base disease modelling and pharmaceutical drug discovery. Specifically, I concentrate on ischaemic heart injury and diabetic cardiomyopathy, aiming to develop novel therapeutics to reduce hospitalisations and community health burdens. I have 13 career publications and an h-index of 5 (Web of Science); 83.3% of my publications are in Q1 journals (SciVal). Across my research career, the topic areas in publications include studies in cell biology (4), development biology (3), pharmacology (3), and cardiovascular system-cardiology (2) (Web of Science). In the last five years, 60% of my publications are in the top 10% of journals, and the studies cover biochemistry, genetics and molecular biology (3 outputs), and medicine (2 outputs) (SciVal). I have held leadership roles including member of International Society for Heart Research Australasia Early Career Investigator Committee, member of the Queensland Cardiovascular Research Network (QCVRN) Emerging Leaders Committee, member of the Early-Mid Career Researchers (EMCR) Association for IMB, UQ. I am organising EMCR Session for the 2024 Cardiac Society of Australia and New Zealand annual scientific meeting, the 2024 QCVRN & Heart Foundation Research Showcase, the 2024 IMB EMCR Retreat meeting, and was organisation committee member for the 2023 Australia Network of Cardiac and Vascular Developmental Biology conference. I review for journals including Stem Cell Reports, Stem Cells, IUBMB Life and co-review for journals including Nature Methods, Cell Stem Cell, Journal of Molecular and Cellular Cardiology. I am a special guest editor for the journal Pathogens on the Special Issue: Innate Immunity against Pathogens.